Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, tolerability and efficacy of RZ-001 in combination with valganciclovir and atezolizumab/bevacizumab in hepatocellula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• RZ-001
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Rznomics, Inc. | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1, Phase 2 | Status: RECRUITING